Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Home
Authors
Posts by Medicines Law & Policy
Medicines Law & Policy
12 POSTS
0 COMMENTS
Uncategorized
US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a reality
Medicines Law & Policy
-
May 6, 2021
0
Uncategorized
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too
Medicines Law & Policy
-
April 13, 2021
0
Blog
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the remarkable example of penicillin production in the United States during World War II.
Medicines Law & Policy
-
April 13, 2021
0
Blog
The European Commission says Covid-19 vaccines should be global public goods, but do their agreements with pharma reflect this?
Medicines Law & Policy
-
January 28, 2021
0
Blog
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
0
Uncategorized
COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach
Medicines Law & Policy
-
June 18, 2020
0
Blog
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to realise equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data
Medicines Law & Policy
-
May 29, 2020
0
Uncategorized
Watch the webinar on the WHO Covid-19 Technology Pool
Medicines Law & Policy
-
May 15, 2020
0
Blog
Drug Price Transparency Calls Move from South Africa to World Health Assembly
Medicines Law & Policy
-
May 18, 2019
0
Blog
WHO Fair Pricing Forum: Watching for Drug Industry Accountability
Medicines Law & Policy
-
April 11, 2019
0
1
2
Page 1 of 2
